Nkx-2.5 Regulates MDR1 Expression via Its Upstream Promoter in Breast Cancer Cells
Journal of Korean Medical Science
;
: e100-2019.
Artigo
em Inglês
| WPRIM
| ID: wpr-764935
ABSTRACT
BACKGROUND:
Increased expression of MDR1 gene is one of the major mechanisms responsible for multidrug resistance in cancer cells. Two alternative promoters, upstream and downstream, are responsible for transcription of MDR1 gene in the human. However, the molecular mechanism regarding the transactivation of MDR1 upstream promoter (USP) has not been determined.METHODS:
Dual-luciferase reporter gene assays were used to assess the effect of Nkx-2.5 on MDR1 USP activity using reporter plasmids for human MDR1 USP and its mutants. MDR1 mRNA level was examined by quantitative real-time PCR. The direct binding of Nkx-2.5 to the USP of MDR1 was evaluated by promoter enzyme immunoassays and chromatin immunoprecipitation assays.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Fenótipo
/
Plasmídeos
/
Mama
/
Neoplasias da Mama
/
RNA Mensageiro
/
Imunoensaio
/
Ativação Transcricional
/
Técnicas Imunoenzimáticas
/
Genes Reporter
/
Resistência a Múltiplos Medicamentos
Limite:
Humanos
Idioma:
Inglês
Revista:
Journal of Korean Medical Science
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS